Programs like 340B originally created as a safeguard for hospitals serving vulnerable populations are likely masking deeper vulnerabilities, with the revenue generated from dispensing specialty medications offsetting the financial impact of declining demand for certain procedures
John Deanfield, director of the National Institute for Cardiovascular Outcomes Research and the lead author of the study, said Tuesday that these anti-obesity drugs could be taken daily for the rest of a patient's life, similar to cholesterol-lowering statins
Theres a local story behind this clinic, too
No statement should be interpreted as a claim to diagnose, treat, cure, or prevent any condition
Unlike many supplements with generous dosing ranges, DSIP works within a relatively narrow effective window
10.1034/j.1600-0838.2001.110606.x 57 HartmanM